Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Medical nonadherence is an infamously expensive detriment to public health, costing pharmaceutical companies billions in lost revenues and leading to poorer patient outcomes. This report looks into what tactics pharma should use to improve patient adherence.
Already a Client? Log in to access this report.